MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2025 International Congress

    Pilot Study: Shear Wave Elastography as a Potential Biomarker in Task-Specific Dystonia

    A. Ly, A. Mushtaheed, A. Roberts, M. Druckenbrod, J. Stowers, M. Soliman, P. Lind, Y. Assefa, C. Stanley, A. Gravunder, J. Matsubara, C. Zampieri-Gallagher, D. Ehrlich, B. Karp, F. Gavelli, K. Alter (Bethesda, USA)

    Objective: The purpose of this study was to explore shear wave elastography (SWE)’s ability to identify task-specific dystonic muscles by determining if muscle stiffness increased…
  • 2025 International Congress

    Comparative Effectiveness of Botulinum Toxin vs. Oral Medications in the Management of Cervical Dystonia: A Multi-Center Study

    A. Chandra, A. Chandra, S. Acharya (Tianjin, China)

    Objective: This study aims to compare the effectiveness of botulinum toxin injections versus oral medications in the symptomatic management of cervical dystonia , evaluating their…
  • 2025 International Congress

    Physician Assessment of Non-Medical Toxin Switching on Patient Care

    P. Charles, L. Venditti, M. Nelson, R. Singh, K. Pazira, H. Kling, L. Kopaeva, S. Sharp, K. Harper (Nashville, USA)

    Objective: To gain an understanding from physicians on the impact of non-medical toxin switching (NMTS) in the treatment of movement disorders and other chronic conditions…
  • 2025 International Congress

    Patient Perspectives on the Therapeutic Effects of Botulinum Toxin in Cervical Dystonia

    M. Relja, D. Dressler, F. Morgante, V. Trjulja (Zagreb, Croatia)

    Objective: To investigate patient perspectives on the therapeutic effects of botulinum toxin type-A  (BoNT-A) in cervical dystonia (CD) using patient s on-line survey. Background: CD…
  • 2025 International Congress

    Precision Management of Oromandibular Dystonia (OMD): The Role of Neurological examination, Electromyographic (EMG) Guidance, and Odontological evaluation (OE) – A descriptive study with a Multidisciplinary Approach for Botulinum Toxin A (BoNT/A) Treatment

    A. Stark, H. Biernat, K. Benedek, P. Mcgettigan, M. Bakke, A. Lokkegaard (Rsokilde, Denmark)

    Objective: To demonstrate the advantages of OE, when facing challenges with identifying patterns of OMD for employment of EMG for guided BoNT/A precision management. Background:…
  • 2025 International Congress

    Use of Botulinum Toxin Application in the Inferior Oblique Capitis Muscle Under Tomographic Guidance in Cervical Dystonia Report of Two Cases

    I. Amorín, A. Rodriguez, N. Sorondo, B. Cardozo (Montevideo, Uruguay)

    Objective: To communicate the advantages of botulinum toxin application for dystonia under tomographic guidance in cervical muscles applying the Col/Cap concept. Background: The first case…
  • 2025 International Congress

    Long-Term Therapeutic Effect of Botulinum Neurotoxin Type A (BoNT-A) in Cervical Dystonia: A Case Series.

    R. Lopez-Castellanos, R. Lopez-Contreras (Boston, USA)

    Objective: To evaluate the long-term therapeutic effect of Botulinum neurotoxin type A (BoNT-A) in cervical dystonia. Background: Cervical dystonia is the most common adult-onset focal…
  • 2025 International Congress

    Development and Testing of a Smartphone Application to Capture Patient-Centered Outcome (PCO) Measures for Dystonia

    P. Reyes, A. Tingin, B. Berman, S. Schneider, J. Hieshetter, K. Kuman, G. Kilic-Berkmen, L. Wright, F. Qeadan, J. Perlmutter, H. Jinnah, S. Pirio-Richardson (Richmond, USA)

    Objective: Develop a smartphone application to collect patient-centered outcome (PCO) measures for dystonia. Background: PCO measures tailored for each major adult-onset focal dystonia subtype (Cervical…
  • 2025 International Congress

    Characteristics of IncobotulinumtoxinA Treatment for Cervical Dystonia in a Real-World Setting: Dosing and Muscles Injected

    J. Holmes, A. Kong, G. Askin, D. Nomah, D. Joseph, K. Biney, M. Hast (Raleigh, USA)

    Objective: To describe incobotulinumtoxinA doses and muscles injected in a real-world setting for patients with cervical dystonia (CD) Background: IncobotulinumtoxinA is approved to treat CD…
  • 2025 International Congress

    Blepharospasm as cause of facial pain and “sinus” headache: A case series

    J. Anang (Winnipeg, Canada)

    Objective: Describe the clinical spectrum of blepharospasm Background: Blepharospasm is characterized by stereotyped, bilateral and synchronous spasms of the orbicularis oculi muscles Method: Case report…
  • 1
  • 2
  • 3
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley